Search

everythinglearnresearchcommunity

for

Search:↓

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Common skin conditions can greatly affect a person's mental health and social life.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

New treatments for hair loss are being developed using molecular biology.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.